Blood holds clues to cancer treatment success
NCT ID NCT06630429
Summary
This study aims to learn if simple blood tests can predict how well patients with lung or kidney cancer will respond to immunotherapy drugs. Researchers will collect blood and stool samples from 100 patients receiving standard immunotherapy treatment to look for patterns. The goal is to find biological markers that might help doctors better understand and monitor treatment effectiveness in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA (RCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.